Evidence map›Paper›PMID 27124303›Full record

ArticlePloS one2016

Genetic Analysis of 'PAX6-Negative' Individuals with Aniridia or Gillespie Syndrome.

Morad Ansari, Jacqueline Rainger, Isabel M Hanson, Kathleen A Williamson, Freddie Sharkey, Louise Harewood, Angela Sandilands, Jill Clayton-Smith, Helene Dollfus, Pierre Bitoun and 43 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinical practice guideline for aniridia.Japanese journal of ophthalmology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 10 countries.

Morad AnsariMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Jacqueline RaingerMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Isabel M HansonMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Kathleen A WilliamsonMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Freddie SharkeyMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Louise HarewoodMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Angela SandilandsMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Jill Clayton-SmithFaculty of Medical and Human Sciences, Manchester Centre for Genomic Medicine, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester, United Kingdom.
Helene DollfusService de Génétique Médicale, Hôpital de Haute-Pierre, Strasbourg, France.
Pierre BitounMedical Genetics Departments, University Hospital Jean Verdier, Bondy, France.
Francoise MeireDepartment of ophthalmopediatrics, Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgium.
Judy FantesMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Brunella FrancoMedical Genetics, Department of Medical Translational Sciences, Federico II University, Naples, Italy.
Birgit LorenzDepartment of Ophthalmology, Justus-Liebig-University Giessen, Universitaetsklinikum Giessen and Marburg UKGM, Giessen, Germany.
David S TaylorInstitute of Child Health, University College London, UK and Great Ormond Street Hospital for Children, London, United Kingdom.
Fiona StewartNorthern Ireland Regional Genetics Service (NIRGS), Belfast City Hospital, Belfast, United Kingdom.
Colin E WilloughbyDepartment of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
Meriel McEntagartMedical Genetics Unit, St George's University of London, London, United Kingdom.
Peng Tee KhawMoorfields Eye Hospital, London, UK and University College London, Institute of Ophthalmology, London, United Kingdom.
Carol ClericuzioDepartment of Pediatric Genetics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Lionel Van MaldergemCentre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
Denise WilliamsClinical Genetics Unit, Birmingham Women's Hospital, Birmingham, United Kingdom.
Ruth Newbury-EcobDepartment of Clinical Genetics, University Hospitals, Bristol, United Kingdom.
Elias I TraboulsiCenter for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, United States of America.
Eduardo D SilvaDepartment Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
Mukhlis M MadlomChildren's Hospital, Doncaster Royal Infirmary, Doncaster, United Kingdom.
David R GoudieHuman Genetics Unit, University of Dundee College of Medicine, Dentistry and Nursing, Ninewells Hospital, Dundee, United Kingdom.
Brian W FleckDepartment of Ophthalmology, Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh, United Kingdom.
Dagmar WieczorekInstitut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
Juergen KohlhaseCenter for Human Genetics, Freiburg, Germany.
Alice D McTrustyDepartment of Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom.
Carol GardinerClinical Genetics, Southern General Hospital, Glasgow, United Kingdom.
Christopher YaleDepartment of Paediatrics and Child Health, Ipswich Hospital, Ipswich, United Kingdom.
Anthony T MooreMoorfields Eye Hospital, London, UK and University College London, Institute of Ophthalmology, London, United Kingdom.
Isabelle Russell-EggittInstitute of Child Health, University College London, UK and Great Ormond Street Hospital for Children, London, United Kingdom.
Lily IslamInstitute of Child Health, University College London, UK and Great Ormond Street Hospital for Children, London, United Kingdom.
Melissa LeesNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street Hospital, London, United Kingdom.
Philip L BealesInstitute of Child Health, University College London, UK and Great Ormond Street Hospital for Children, London, United Kingdom.
Stephen J TuftMoorfields Eye Hospital, London, UK and University College London, Institute of Ophthalmology, London, United Kingdom.
Juan B SolanoRuber International Hospital, Medical Genetics Unit, Mirasierra, Madrid, Spain.
Miranda SplittNorthern Genetics Service, Institute of Genetic Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Jens Michael HertzDepartment of Clinical Genetics, Odense University Hospital, Odense C, Denmark.
Trine E PrescottDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Deborah J ShearsDepartment of Clinical Genetics, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
Ken K NischalUPMC Eye Center, Children's Hospital of Pittsburgh of UPMC, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Martine Doco-FenzyService de génétique, HMB CHU Reims, SFR Cap Sante. EA 3801, France.
Fabienne PrieurCHU de Saint Etienne, Service de génétique médicale, Saint-Etienne, France.
I Karen TempleAcademic Unit of Genetic Medicine, Division of Human Genetics, University of Southampton, Southampton, United Kingdom.
Katherine L LachlanWessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Giuseppe DamanteDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy.
Danny A MorrisonSt. Thomas' Hospital, Westminster Bridge Road, London, United Kingdom.
Veronica van HeyningenMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
David R FitzPatrickMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.
Western General Hospital · GBGreat Ormond Street Hospital · GBMoorfields Eye Hospital NHS Foundation Trust · GBBirmingham Women's Hospital · GBCentre Hospitalier Universitaire de Reims · FRCentre Hospitalier Universitaire de Saint-Étienne · FRChurchill Hospital · GBCleveland Clinic · USDoncaster Royal Infirmary · GBDüsseldorf University Hospital · DEFederico II University Hospital · ITGlasgow Caledonian University · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBHôpital d'Hautepierre · FRHôpital Jean-Verdier · FRHospital Ruber Internacional · ESIpswich Hospital · GBJustus-Liebig-Universität Gießen · DEManchester Academic Health Science Centre · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

Medical Research Council MC_PC_U127527199Medical Research Council MC_PC_U127561093Medical Research Council MC_U127527199Medical Research Council MC_U127561093
6 · The paper itself

Abstract

We report molecular genetic analysis of 42 affected individuals referred with a diagnosis of aniridia who previously screened as negative for intragenic PAX6 mutations. Of these 42, the diagnoses were 31 individuals with aniridia and 11 individuals referred with a diagnosis of Gillespie syndrome (iris hypoplasia, ataxia and mild to moderate developmental delay). Array-based comparative genomic hybridization identified six whole gene deletions: four encompassing PAX6 and two encompassing FOXC1. Six deletions with plausible cis-regulatory effects were identified: five that were 3' (telomeric) to PAX6 and one within a gene desert 5' (telomeric) to PITX2. Sequence analysis of the FOXC1 and PITX2 coding regions identified two plausibly pathogenic de novo FOXC1 missense mutations (p.Pro79Thr and p.Leu101Pro). No intragenic mutations were detected in PITX2. FISH mapping in an individual with Gillespie-like syndrome with an apparently balanced X;11 reciprocal translocation revealed disruption of a gene at each breakpoint: ARHGAP6 on the X chromosome and PHF21A on chromosome 11. In the other individuals with Gillespie syndrome no mutations were identified in either of these genes, or in HCCS which lies close to the Xp breakpoint. Disruption of PHF21A has previously been implicated in the causation of intellectual disability (but not aniridia). Plausibly causative mutations were identified in 15 out of 42 individuals (12/32 aniridia; 3/11 Gillespie syndrome). Fourteen of these mutations presented in the known aniridia genes; PAX6, FOXC1 and PITX2. The large number of individuals in the cohort with no mutation identified suggests greater locus heterogeneity may exist in both isolated and syndromic aniridia than was previously appreciated.

Indexed as

AniridiaCerebellar AtaxiaChromosomes, Human, Pair 11Chromosomes, Human, XComparative Genomic HybridizationFemaleForkhead Transcription FactorsGenetic TestingGTPase-Activating ProteinsHistone DeacetylasesHomeobox Protein PITX2Homeodomain ProteinsHumansIntellectual DisabilityMaleMutationARHGAP6 protein, humanForkhead Transcription FactorsFOXC1 protein, humanGTPase-Activating ProteinsHistone DeacetylasesHomeobox Protein PITX2Homeodomain ProteinsPAX6 protein, humanPAX6 Transcription FactorPHF21A protein, humanTranscription Factors

Identifiers

PMID27124303
PMCPMC4849793
OpenAlexW2342785795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.